Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
10 Patents
#281 in Irvine, CA
#7,114 in California
#29,866 in US
#56,047 in the World
Nexell Therapeutics Inc.
Forward Citations = 168
18 inventors:
Irvine, CA, United States of America
Nexell Therapeutics Inc.
Forward Citations = 168
Loading Chart...
Loading Chart...
18 inventors (with patents filed for the assignee):
Dennis E Van Epps (7 out of 10 patents)
James G Bender (6 out of 10 patents)
Stephen L Smith (6 out of 10 patents)
4. Kristen L Unverzagt (3 out of 5 patents)
5. Phillip B Maples (3 out of 4 patents)
6. Maureen F Loudovaris (3 out of 3 patents)
7. Susan M Maciukas (3 out of 3 patents)
8. Xiaoying Qiao (3 out of 3 patents)
9. Sam L Helgerson (2 out of 8 patents)
10. Robert J Deans (2 out of 2 patents)
11. Roy Guillermo (2 out of 2 patents)
12. Fahad A Al-Abdaly (2 out of 2 patents)
13. Joan A Kobori (2 out of 2 patents)
14. Janet Tseng-Law (2 out of 2 patents)
15. Mona Vachula (1 out of 1 patent)
10 patents:
5. 6017719 - Positive and positive/negative cell selection mediated by peptide release (2000-01-25),
Company Overview
Nexell Therapeutics Inc. is a biotechnology company based in Irvine, California, specializing in the development of innovative cell therapies. The organization focuses on harnessing the potential of stem cells to create advanced treatments for various diseases, particularly in the fields of regenerative medicine and immunotherapy. By leveraging cutting-edge research and technology, Nexell aims to address significant unmet medical needs and improve patient outcomes through its pioneering therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nexell Therapeutics Inc.. Retrieved from https://idiyas.com/company/nexell-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]